Erik W. Jakobsen of Norwegian consultancy Menon Economics gives an overview of the key dynamics at play in Norway’s economy today and the growing role that healthcare and the life sciences plays within it. Jakobsen touches on why Norway needs to become more competitive as a life sciences investment destination, the challenges of scaling-up and commercialising Norwegian innovation, and why stakeholders from both the public and private sectors need to be on the same page to see this push through.
It will take some time but if the industry is able to continue to produce talent, new technology and solutions, diagnostic tools, and treatments, gradually the capital will also be provided
